Heron Therapeutics Inc Forecast, price target & analysts
Heron Therapeutics Inc Target price 2026 - Analyst rating & recommendation
Heron Therapeutics Inc Classifications & Recommendation
Heron Therapeutics Inc Price Target
| Target Price | $2.55 |
| Price | $0.35 |
| Potential |
633.60%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Heron Therapeutics Inc 2027 .
The average Heron Therapeutics Inc target price is $2.55.
This is
633.60%
register free of charge
$3.15
806.21%
register free of charge
$2.02
481.13%
register free of charge
|
|
| A rating was issued by 7 analysts: 0 Analysts recommend Heron Therapeutics Inc to buy, 4 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Heron Therapeutics Inc stock has an average upside potential 2027 of
633.60%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 154.90 | 151.22 |
| 7.35% | 2.38% | |
| Net Margin | -13.04% | -16.87% |
| 38.56% | 29.36% |
4 Analysts have issued a sales forecast Heron Therapeutics Inc 2026 . The average Heron Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
4 Heron Therapeutics Inc Analysts have issued a net profit forecast 2026. The average Heron Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.12 | -0.13 |
| 33.33% | 8.33% | |
| P/E | negative | |
| EV/Sales | 1.10 |
4 Analysts have issued a Heron Therapeutics Inc forecast for earnings per share. The average Heron Therapeutics Inc EPS is
This results in the following potential growth metrics and future valuations:
Heron Therapeutics Inc...
Current Heron Therapeutics Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jun 03 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Jun 03 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 09 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jun 09 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Apr 11 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 11 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jun 03 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Jun 03 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 09 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Aug 08 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jun 09 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Apr 11 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
